Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Sulforaphane as an Antagonist to Human PXR-mediated Drug-drug Interactions

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborators:
Fred Hutchinson Cancer Research Center
National Institute of General Medical Sciences (NIGMS)
Information provided by:
University of Washington
ClinicalTrials.gov Identifier:
NCT00621309
First received: February 12, 2008
Last updated: November 12, 2009
Last verified: November 2009
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: September 2010
  Estimated Primary Completion Date: June 2010 (Final data collection date for primary outcome measure)